Who owns NEUROSENSE THERAPEUTICS LTD?
- Ticker: NRSN
- CUSIP Number: m74240108
Tip: Access positions for across all investors
Analyze quarterly positions in Neurosense Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Neurosense Therapeutics stock
Who bought or sold NEUROSENSE THERAPEUTICS LTD this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Yorkville Advisors Global | 100k | $77k | 100% | Dec 2025 |
|
| Meitav Dash Investments | 40k | $31k | 0% | Dec 2025 |
|
| Gts Securities | 36k | $28k | 100% | Dec 2025 |
|
| UBS Group | 31k | $24k | 111% | Dec 2025 |
|
| Commonwealth Equity Services | 23k | $18k | 8% | Dec 2025 |
|
| Two Sigma Investments | 21k | $26k | 100% | Sep 2025 |
|
| Squarepoint Ops | 18k | $14k | -81% | Dec 2025 |
|
| Pathstone Holdings | 17k | $13k | 100% | Dec 2025 |
|
| Geode Capital Management | 16k | $12k | 0% | Dec 2025 |
|
| Creative Planning | 12k | $9.2k | 100% | Dec 2025 |
|
| SBI Securities | 1.5k | $1.1k | 0% | Dec 2025 |
|
| Jones Financial Companies, L.L | 1.0k | $769.000000 | 0% | Dec 2025 |
|
| Jessup Wealth Management | 500.00 | $385.000000 | 100% | Dec 2025 |
|
Who sold out of Neurosense Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Citadel Advisors | Jun 2025 | 149k | $282k |
| CWM | Sep 2025 | 1.0k | $1.0k |